Athenex Announces Third Quarter 2018 Financial Results and Provides Corporate Update Pharmaceutical Investing
Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder Pharmaceutical Investing
MediPharm Labs Signs The Supreme Cannabis Company for Cannabis Concentrate Program Cannabis Investing News
Isodiol International Inc. & Brew Hub, LLC Announce Agreement for the Development of Hemp Beer and Related Functional Beverages Cannabis Investing News
Leading Burn Surgeons Present Positive RECELL System Results at 31st Annual Southern Region Burn CME Conference Biotech Investing
Nightstar Announces Planned Initiation of Phase 2/3 Expansion Study in XIRIUS Trial for NSR-RPGR in XLRP Genetics Investing
